Frederico Friedrich

Dr. Frederico Friedrich


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in Pediatric Pulmonology
Verified
Journal Article
Open access
PDF file
FFFrederico Friedrich
Frederico Friedrich
LGLaura de Castro e Garcia
Laura de Castro e Garcia
LPLucas Montiel Petry
Lucas Montiel Petry
MPMarina Puerari Pieta
Marina Puerari Pieta
GCGustavo Eggers Carvalho
Gustavo Eggers Carvalho
LPLeonardo Araújo Pinto
Leonardo Araújo Pinto
Background and Objective: The knowledge about the impact of the nonpharmacological measures to control the COVID‐19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID‐19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil.Methods: Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015–2020 and analyzed by macroregions and age groups. To evaluate the effect of containment measures, on the incidence of pneumonia, the absolute reduction and relative reduction were calculated by analyzing the subsets 2015‐2019 vs. 2020.Results: Comparing the subsets of April–August 2015–2019 vs. April–August 2020 for Brazil (total), there was an significant reduction in the average incidence of hospitalizations, with numbers ranging from −82% [IRR 0.17 (0.14–0.21)] for <4 years (prepandemic 741.8/100,000 vs. pandemic 132.7/100.000), −83% [IRR 0.17 (0.10–0.27)] for 5–9 years (prepandemic 113.6/100,000 vs. pandemic 19.6/100.000), −77% [IRR 0.23 (0.11–0.46)] for 10–14 (prepandemic 42.0/100,000 vs. pandemic 9.8/100.000) and −82% [IRR 0.18 (0.15–0.21)] for all children ≤14 years (prepandemic 897.4/100,000 vs. pandemic 162.1/100.000).Conclusion: We found a significant decrease in cases of all cause pneumonia in children under 14 years and especially in the age group <9 years during the COVID‐19 pandemic, which may be associated with the nonpharmacological measures applied to control the SARS‐CoV‐2.

28 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FFFrederico Friedrich
Frederico Friedrich
MVMaria Clara Valadão
Maria Clara Valadão
MBMarcos Brum
Marcos Brum
TCTalitha Comaru
Talitha Comaru
PPPaulo Márcio Pitrez
Paulo Márcio Pitrez
MSMarcelo C. Scotta
Marcelo C. Scotta
Pertussis is an important public health problem worldwide, especially in infants. An increase in the incidence in many countries occurred after 2010, including Brazil. In 2013, dTpa vaccine was introduced in the Brazil national immunization schedule of pregnant women. The objective of this study was to evaluate the national trends in the incidence of pertussis in Brazil in children under 1 year old, and the impact of the introduction of dTpa vaccine during pregnancy. The incidence of hospitalizations and non-hospitalized confirmed cases of pertussis in neonates (< 1 month age) and young infants (1 month—< 1 year age) were analyzed, comparing the incidence in pre maternal vaccination (2011–2013) with the post-vaccination (2015–2017). We used non-respiratory hospitalizations as comparison, during the same period. A database of the Brazilian Ministry of Health (DATASUS) was used to analyze cases from 2007 to 2017 and the subsets of 2011–2013 and 2015–2017, after Pertussis resurgence. The vaccination data was accessed through the link of the Information System of the National Immunization Program (pni.datasus.gov.br). Between 2007 and 2017, 17,818 children under one year of age were hospitalized due to pertussis in Brazil. In the pre maternal vaccination period 2011–2013, the mean annual incidence of non-hospitalized confirmed cases of pertussis in children under 1 month was 722.2 / 100,000 and in the period of 2015–2017 the average was 377.3 / 100,000, representing a decrease of 47.7% [IRR 0.52 (0.46–0.59)]. At those periods of time, the average incidence per year for children of one month—< 1 year aged was 64.9 / 100,000 (2011–2013) and 29.3 / 100,000 (2015–2017) [IRR 0.45 (CI 0.29–0.69)]. Vaccination of pregnant woman coincides with the reduction in the number of cases of pertussis in children under 1 month of age from 2015. Immunization of pregnant woman seems to have an important impact on the prevention of the disease in young infants who have not yet received their own pertussis vaccine.

31 December 2021 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
CJClovisa Reck de Jesus
Clovisa Reck de Jesus
ARAline Antônia Souto Rosa
Aline Antônia Souto Rosa
AMAmanda da Silva Meneses
Amanda da Silva Meneses
AAAngélica Conzati Agostini
Angélica Conzati Agostini
FMFernanda Bercht Merten
Fernanda Bercht Merten
LPLeonardo Araújo Pinto
Leonardo Araújo Pinto
Objective: The objective of this study is to evaluate the impact of social distancing resulting from COVID-19 in hospitalizations for infections of the upper airways (URTI), such as acute laryngitis, tracheitis, and otitis media in children aged 0 to 9 years in Brazil, considering that they share the same forms of transmission. Methods: Data on hospitalizations for acute airway changes and their complications in children <9 years old were obtained from the Database of the Brazilian Department of Public Health Informatics for the period 2015 to 2020. These data were also analyzed by macroregions of Brazil (North, Northeast, Southeast, South, and Midwest). The effect of the social distancing strategy on the increase of acute laryngitis, tracheitis, otitis media, and mastitis, as absolute and relative reductions, was calculated by analyzing the annual calculation of 2015-2019 vs 2020. Results: All the hospitalizations compared in the Unified Health System (SUS) for laryngitis and acute tracheitis and otitis media decreased, considering all states of Brazil. The largest reduction in hospitalization reduction was in the North, with -94% in 2015-2019 vs 2020 in cases of laryngitis and acute tracheitis, and in the Midwest, with - 85% in 2015-2019 vs 2020 in cases of otitis media. Conclusion: Hospitalizations for laryngitis, acute tracheitis, and acute otitis media in children <9 years old decreased between March and July 2020 in Brazil, when social distancing measures were adopted due to the COVID-19 pandemic.

19 February 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
FSFátima Cleonice de Souza
Fátima Cleonice de Souza
MMMagáli Mocellin
Magáli Mocellin
RORenata Ongaratto
Renata Ongaratto
LLLidiane Alves de Azeredo Leitão
Lidiane Alves de Azeredo Leitão
FFFrederico Friedrich
Frederico Friedrich
LPLeonardo Araújo Pinto
Leonardo Araújo Pinto
To compare the frequency of respiratory tract infections in children treated with OM-85 BV and placebo during the 3-month therapy period, and observation for a further 3 months after treatment. A randomized, double-blind, placebo-controlled trial was conducted with 54 children (6 months to 5 years old) with no past history of recurrent respiratory infections attending daycare center. Family members were instructed to administer one capsule per day for 10 consecutive days, for 3 months of OM-85 BV or placebo. Telephone interviews were conducted every 30 days. There was no significant difference in the number of respiratory infections between the groups. The mean number of respiratory tract infection in the OM-85 BV Group in the first 3 months was 0.92±0.87, and in the Placebo Group was 0.74±1.02, and at 6 months it was 1.62±1.47 and 1.03±1.34, respectively. OM-85 BV was not effective in the primary prevention of respiratory tract infections. Although most authors recommend the use of this immunostimulant in children with a history of recurrent respiratory infections, more studies are needed to define its usefulness in the primary prevention of respiratory infections in healthy children exposed to few risk factors.

25 March 2020 in Scientia Medica
Verified
Journal Article
Open access
PDF file
FSFilipe José Da Silveira
Filipe José Da Silveira
VOVinícius da Silva Lessa De Oliveira
Vinícius da Silva Lessa De Oliveira
FFFrederico Friedrich
Frederico Friedrich
JHJoão Paulo Heinzmann-Filho
João Paulo Heinzmann-Filho
Objetivos: verificar o número e as causas de hospitalizações por quedas em idosos brasileiros, além dos gastos federais do Sistema Único de Saúde (SUS), no período de 2000 a 2018.Métodos: trata-se de um estudo ecológico, utilizando informações disponíveis na base de dados do Departamento de Informática do SUS. Foram coletados dados de idosos (≥60 anos) que internaram no SUS devido às quedas no período de 2000 a 2018 no Brasil. Extraíram-se o número de hospitalizações no País e nas regiões (Norte, Nordeste, Sul, Sudeste e Centro-Oeste), as causas das quedas (Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde – 10) e o valor de gastos federais. Para fins estatísticos, utilizou-se análise descritiva.Resultados: totalizaram-se 1,48 milhões de hospitalizações por quedas em idosos no Brasil, com uma taxa de 38,6 a cada 10 mil. As principais causas desses registros no DATASUS foram as “quedas sem especificações”, as “outras quedas no mesmo nível” e as “quedas no mesmo nível por escorregão, tropeção ou passos em falsos”. Em relação às localidades, os idosos pertencentes às regiões Sudeste (47,1), Sul (44,1) e Centro-Oeste (40,4) foram aqueles que apresentaram maiores medianas das taxas de hospitalizações por quedas no período analisado. Entretanto, o Nordeste (variação%=0,4), o Sul (variação%=0,2) e o Centro-Oeste (variação%=0,2) demonstraram maiores elevações desse indicador ao longo dos 18 anos, enquanto apenas a região Norte apresentou redução (variação%=-0,5). A mediana de gastos hospitalares federais (milhões) foi de R$135,58, variando de R$112,89 até R$194,98.Conclusões: houve aumento das taxas de hospitalizações por quedas em idosos no SUS em quase todas as unidades federativas. As causas mais frequentes foram as “quedas sem especificações”, as “outras quedas no mesmo nível” e as “quedas no mesmo nível por escorregão, tropeção ou passos em falsos”. Além disso, ocorreu elevação dos gastos hospitalares federais ao longo do período no País.

7 February 2022 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
BABruna Freire Accorsi
Bruna Freire Accorsi
FFFrederico Friedrich
Frederico Friedrich
ACAndréa L. Lúcia Corso
Andréa L. Lúcia Corso
JRJuliana Pontes da Rosa
Juliana Pontes da Rosa
MJMarcus Herbert Jones
Marcus Herbert Jones
Objective: To assess respiratory system impedance (Z(rs)) and spirometric parameters in children and adolescents with and without a history of preterm birth. Methods: We evaluated a sample of 51 subjects between 11 and 14 years of age: 35 who had a history of preterm birth (preterm group) and 16 who had been born at term (full-term group). Lung function was measured by spirometry, spectral oscillometry, and intra-breath oscillometry. Results: Neither spirometry nor spectral oscillometry revealed any statistically significant differences between the preterm and full-term groups. However, intra-breath oscillometry demonstrated significant differences between the two groups in terms of the change in resistance, reactance at end-inspiration, and the change in reactance (p < 0.05 for all). Conclusions: Our findings suggest that abnormalities in Z(rs) persist in children and adolescents with a history of preterm birth and that intra-breath oscillometry is more sensitive than is spectral oscillometry. Larger studies are needed in order to validate these findings and to explore the impact that birth weight and gestational age at birth have on Z(rs) later in life.